The present invention relates to further medical uses for a botanical drug or dietary supplement consisting essentially of four botanical drug substances, optionally formulated with excipients. The botanical raw materials, botanical drug substances or botanical ingredients used are from a species of each of the genera (a) Silybum; (b) Astragalus or Hedysarum; (c) Salvia; and (d) Schisandra.